Estimating human papillomavirus vaccination coverage among young women in Victoria and reasons for non-vaccination
Julia M. L. Brotherton A C , Leonard S. Piers B and Loretta Vaughan BA National HPV Vaccination Program Register, VCS Inc., PO Box 310, East Melbourne, Vic. 8002, Australia.
B Health Intelligence Unit, Department of Health, 50 Lonsdale Street, Melbourne, Vic. 3000, Australia.
C Corresponding author. Email: jbrother@vcs.org.au
Sexual Health 13(2) 190-192 https://doi.org/10.1071/SH15131
Submitted: 24 June 2015 Accepted: 13 October 2015 Published: 30 November 2015
Abstract
Background: Adult Australian women aged 18 to 26 years were offered human papillomavirus (HPV) vaccine in a mass catch up campaign between 2007 and 2009. Not all doses administered were notified to Australia’s HPV vaccine register and not all young women commenced or completed the vaccine course. Methods: We surveyed vaccine age-eligible women as part of the Victorian Population Health Survey 2011–2012, a population based telephone survey, to ascertain self-reported vaccine uptake and reasons for non-vaccination or non-completion of vaccination among young women resident in the state of Victoria, Australia. Results: Among 956 women surveyed, 62.3 per cent (57.8–66.6%) had been vaccinated against HPV and coverage with three doses was estimated at 53.7 per cent (49.1–58.2%). These estimates are higher than register-based estimates for the same cohort, which were 57.8 per cent and 37.2 per cent respectively. A lack of awareness about needing three doses and simply forgetting, rather than fear or experience of side effects, were the most common reasons for failure to complete all three doses. Among women who were not vaccinated, the most frequent reasons were not knowing the vaccine was available, perceiving they were too old to benefit, or not being resident in Australia at the time. Conclusions: It is likely that at least half of Victoria’s young women were vaccinated during the catch-up program. This high level of coverage is likely to explain the marked reductions in HPV infection, genital warts and cervical disease already observed in young women in Victoria.
References
[1] Gertig DM, Brotherton JML, Saville M. Methods for measuring HPV vaccination coverage and the role of the National HPV Vaccination Program Register, Australia. Sex Health 2011; 8 171–8.| Methods for measuring HPV vaccination coverage and the role of the National HPV Vaccination Program Register, Australia.Crossref | GoogleScholarGoogle Scholar | 21592430PubMed |
[2] Brotherton J, Gertig D, Chappell G, Rowlands L, Saville M. Catching up with the catch-up: HPV vaccination coverage data for Australian women aged 18–26 years from the National HPV Vaccination Program Register. Commun Dis Intell 2011; 35 197–201.
[3] Brotherton JML, Fridman M, May C, Chappell G, Saville AM, Gertig DM. Early effect of the HPV vaccination program on cervical abnormalities in Victoria, Australia: an ecological study. Lancet 2011; 377 2085–92.
| Early effect of the HPV vaccination program on cervical abnormalities in Victoria, Australia: an ecological study.Crossref | GoogleScholarGoogle Scholar |
[4] Gertig DM, Brotherton JML, Budd AC, Drennan K, Chappell G, Saville AM. Impact of a population – based HPV vaccination program on cervical abnormalities: a data linkage study. BMC Med 2013; 11 227
| Impact of a population – based HPV vaccination program on cervical abnormalities: a data linkage study.Crossref | GoogleScholarGoogle Scholar | 24148310PubMed |
[5] Department of Health. Victorian Population Health Survey 2011–12. Melbourne, Victoria, 2014. Available online at: http://www.health.vic.gov.au/healthstatus/survey/vphs2011-12.htm [verified 30 Jan 2015].
[6] Brotherton JML, Liu B, Donovan B, Kaldor JM, Saville M. Human papillomavirus (HPV) vaccination coverage in young Australian women is higher than previously estimated: independent estimates from a nationally representative mobile phone survey. Vaccine 2014; 32 592–7.
| Human papillomavirus (HPV) vaccination coverage in young Australian women is higher than previously estimated: independent estimates from a nationally representative mobile phone survey.Crossref | GoogleScholarGoogle Scholar |
[7] Watson M, D’Onise K, Lynch J, Brotherton JML. Barriers to better three-dose coverage with HPV vaccination in school based programs? Aust N Z J Public Health 2014; 38 91–2.
| Barriers to better three-dose coverage with HPV vaccination in school based programs?Crossref | GoogleScholarGoogle Scholar | 24494957PubMed |
[8] Brotherton JML, Murray SL, Hall MA, Andrewartha LK, Banks CA, Meijer D, Pitcher HC, Scully MM, Molchanoff L. Human papillomavirus vaccine coverage among female Australian adolescents: success of the school-based approach. Med J Aust 2013; 199 614–7.
| Human papillomavirus vaccine coverage among female Australian adolescents: success of the school-based approach.Crossref | GoogleScholarGoogle Scholar |
[9] Brotherton JM, Mullins RM. Will vaccinated women attend cervical screening? A population based survey of human papillomavirus vaccination and cervical screening among young women in Victoria, Australia. Cancer Epidemiol 2012; 36 298–302.
| Will vaccinated women attend cervical screening? A population based survey of human papillomavirus vaccination and cervical screening among young women in Victoria, Australia.Crossref | GoogleScholarGoogle Scholar | 22204834PubMed |
[10] Weisberg E, Bateson D, McCaffery K, Skinner SR. HPV vaccination catch up program—utilisation by young Australian women. Aust Fam Physician 2009; 38 72–6.
| 19283241PubMed |
[11] Schmidt S, Parsons HM. Vaccination interest and trends in human papillomavirus vaccine uptake in young adult women aged 18 to 26 years in the United States: an analysis using the 2008–2012 National Health Interview Survey. Am J Public Health 2014; 104 946–53.
| Vaccination interest and trends in human papillomavirus vaccine uptake in young adult women aged 18 to 26 years in the United States: an analysis using the 2008–2012 National Health Interview Survey.Crossref | GoogleScholarGoogle Scholar | 24625152PubMed |
[12] Joura EA, Giuliano AR, Iversen O-E, Bouchard C, Mao C, Mehlsen ED, et al A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med 2015; 372 711–23.
| A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC2MXktF2rsb0%3D&md5=c2a2d8c45df815906e8a6cd658d9f862CAS | 25693011PubMed |
